Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Journal Club
  • Published:

What is the minimum duration of cycled phototherapy that is still effective in treating hyperbilirubinemia?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Watchko JF, Maisels MJ. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed. 2003;88:F455–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Ruud Hansen TW. Phototherapy for neonatal jaundice-therapeutic effects on more than one level? Semin Perinatol. 2010;34:231–4.

    Article  PubMed  Google Scholar 

  3. Tyson JE, Pedroza C, Langer J, Green C, Morris B, Stevenson D, et al. Does aggressive phototherapy increase mortality while decreasing profound impairment among the smallest and sickest newborns? J Perinatol. 2012;32:677–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Brown AK, Kim MH, Wu PY, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics 1985;75:393–400.

    Article  CAS  PubMed  Google Scholar 

  5. Lipsitz PJ, Gartner LM, Bryla DA. Neonatal and infant mortality in relation to phototherapy. Pediatrics 1985;75:422–6.

    Article  CAS  PubMed  Google Scholar 

  6. Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O’Shea TM, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N. Engl J Med. 2008;359:1885–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Arnold C, Pedroza C, Tyson JE. Phototherapy in ELBW newborns: does it work? Is it safe? The evidence from randomized clinical trials. Semin Perinatol. 2014;38:452–64.

    Article  PubMed  Google Scholar 

  8. Vreman HJ, Wong RJ, Stevenson DK. Phototherapy: current methods and future directions. Semin Perinatol. 2004;28:326–33.

    Article  PubMed  Google Scholar 

  9. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235:1043–6.

    Article  CAS  PubMed  Google Scholar 

  10. Speck WT, Rosenkranz HS. Intracellular deoxyribonucleic acid-modifying activity of phototherapy lights. Pediatr Res. 1976;10:553–5.

    Article  CAS  PubMed  Google Scholar 

  11. Auger N, Laverdière C, Ayoub A, Lo E, Luu TM. Neonatal phototherapy and future risk of childhood cancer. Int J Cancer. 2019;145:2061–9.

    Article  CAS  PubMed  Google Scholar 

  12. Tatli MM, Minnet C, Kocyigit A, Karadag A. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates. Mutat Res. 2008;654:93–5.

    Article  CAS  PubMed  Google Scholar 

  13. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297–316.

    Article  Google Scholar 

  14. Ramy N, Ghany EA, Alsharany W, Nada A, Darwish RK, Rabie WA, et al. Jaundice, phototherapy and DNA damage in full-term neonates. J Perinatol. 2016;36:132–6.

    Article  CAS  PubMed  Google Scholar 

  15. Tyson JE Cycled phototherapy: a safer effective method to control the serum bilirubin of extremely premature infants? ClinicalTrials.gov Identifier: NCT03927833. Updated March 27, 2023. Accessed March, 2023. https://clinicaltrials.gov/ct2/show/study/NCT03927833

  16. Millen GC, Yap C. Adaptive trial designs: what are multiarm, multistage trials? Arch Dis Child Educ Pr Ed. 2020;105:376–8.

    Google Scholar 

Download references

Acknowledgements

The Journal club is a collaboration between the American Academy of Pediatrics-Section of Neonatal-Perinatal Medicine and the International Society for Evidence-based neonatology (EBNEO.org).

Author information

Authors and Affiliations

Authors

Contributions

PS conducted the literature review and primarily drafted the manuscript. SM helped develop the concept of the manuscript and assisted in its drafting. Both authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Puneet Sharma.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sharma, P., Mukthapuram, S. What is the minimum duration of cycled phototherapy that is still effective in treating hyperbilirubinemia?. J Perinatol 43, 1449–1451 (2023). https://doi.org/10.1038/s41372-023-01759-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41372-023-01759-5

Search

Quick links